secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001140361-26-015990
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics stockholders approve doubling authorized shares to 250M at annual meeting
--------------------------------------------------------------------------------

- Stock increase proposal passed: 45,360,642 for, 1,486,247 against, 429,479 abstentions.
- Say-on-pay approved with 34,862,743 votes for, 259,749 against, 110,779 abstentions.
- All nine board nominees elected, each receiving over 33.8M votes for.
- Ernst & Young ratified as independent auditor for FY 2026.
- Meeting held April 20, 2026; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/0001140361-26-015990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/ef20071112_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-015990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer